Utesch D, Glatt H, Oesch F
Cancer Res. 1987 Mar 15;47(6):1509-15.
7,12-Dimethylbenz(a)anthracene, benz(a)anthracene, and benzo(a)pyrene as well as the 24 monomethylbenzo(a)pyrenes (MBPs) and monomethylbenz(a)anthracenes (MBAs), compounds which differ in carcinogenicity from very potent to apparently inactive, were investigated for mutagenicity (reversion to histidine prototrophy) in Salmonella typhimurium TA100 using either intact or NADPH-fortified homogenized rat hepatocytes for metabolic activation. In both systems, all 27 hydrocarbons showed positive responses. Their mutagenic potency in the homogenate-mediated test varied in a narrow range and did not correlate detectably with their reported activity in carcinogenicity experiments. When the cell homogenate was replaced by intact cells, the maximal mutagenic effects were weaker by factors of 1 to 14, depending on the compound, and were seen only at higher substrate concentrations. The differences between cell- and homogenate-mediated mutagenicity were small with the strong carcinogens 7,12-dimethylbenz(a)anthracene 7-MBA, 12-MBA, benzo(a)pyrene, 1-MBP, and 11-MBP. The differences were large with the apparent noncarcinogens and those weak carcinogens that were strongly mutagenic in the homogenate-mediated test. As a result of this differential reduction in activity, the cell-mediated mutagenicity did not correlate with the homogenate-mediated mutagenicity but correlated approximately with the carcinogenic potency. The lowest effects in the cell-mediated experiments were seen with 7-, 8-, 9- and 10-MBP, 2-MBA, and 3-MBA. In these compounds, the methyl group is attached to a carbon of the terminal angular benzo ring, and therefore bay-region diol-epoxides, if formed at all, additionally would carry a methyl group on one of the oxidized positions. On the other hand, among all the compounds tested 7,12-dimethylbenz(a)anthracene, 12-MBA, and 11-MBP, which have the methyl group attached in the bay-region position opposite the terminal benzo ring, showed the highest mutagenic efficacies in the cell-mediated test, as compared to those observed in the homogenate-mediated test. These structure-activity relationships and the previously reported observation that among various promutagenic benzo(a)pyrene metabolites only the 7,8-dihydrodiol was strongly mutagenic in the cell-mediated test would suggest that in the cell-mediated bacterial mutagenicity test, bay-region diol-epoxides are the ultimate mutagens which are preferentially detected.
研究了7,12 - 二甲基苯并(a)蒽、苯并(a)蒽、苯并(a)芘以及24种单甲基苯并(a)芘(MBP)和单甲基苯并(a)蒽(MBA),这些化合物的致癌性从极强到明显无活性各不相同,利用完整的或经NADPH强化的大鼠肝匀浆进行代谢活化,在鼠伤寒沙门氏菌TA100中检测它们的致突变性(回复为组氨酸原养型)。在这两种体系中,所有27种烃类都呈现阳性反应。它们在匀浆介导试验中的致突变效力在较窄范围内变化,与它们在致癌性实验中报道的活性没有明显相关性。当用完整细胞取代细胞匀浆时,最大致突变效应减弱1至14倍,具体取决于化合物,且仅在较高底物浓度下才可见。对于强致癌物7,12 - 二甲基苯并(a)蒽、7 - MBA、12 - MBA、苯并(a)芘、1 - MBP和11 - MBP,细胞介导和匀浆介导的致突变性差异较小。对于明显的非致癌物以及在匀浆介导试验中具有强致突变性的弱致癌物,差异则较大。由于活性的这种差异降低,细胞介导的致突变性与匀浆介导的致突变性不相关,但大致与致癌效力相关。在细胞介导实验中效应最低的是7 -、8 -、9 - 和10 - MBP、2 - MBA和3 - MBA。在这些化合物中,甲基连接在末端角状苯环的一个碳原子上,因此,如果形成湾区二醇环氧化物,在氧化位置之一上还会带有一个甲基。另一方面,在所有测试的化合物中,7,12 - 二甲基苯并(a)蒽、12 - MBA和11 - MBP的甲基连接在与末端苯环相对的湾区位置,与在匀浆介导试验中观察到的相比,在细胞介导试验中显示出最高的致突变效力。这些构效关系以及先前报道的观察结果,即在各种前诱变剂苯并(a)芘代谢物中,只有7,8 - 二氢二醇在细胞介导试验中具有强致突变性,这表明在细胞介导的细菌致突变性试验中,湾区二醇环氧化物是优先被检测到的最终诱变剂。